Table 3

OR and 95% CI between hyperuricaemia and AF prevalence

GroupSubjects (n)AFPrevalence (%)Unadjusted modelAdjusted model
OR (95% CI)P valueOR (95% CI)P value
Men*4686350.74
Normal SUA level3844290.751.0001.00001.0001.0000
Hyperuricaemia84260.710.944 (0.391 to 2.281)0.901.025 (0.400 to 2.626)0.96
Women*4251180.42
Normal SUA level3896110.281.0001.00001.0001.0000
Hyperuricaemia35571.977.104 (2.737 to 18.442)<0.0016.366 (2.553 to 15.871)<0.001
Total †8937530.60
Normal SUA level7740400.521.0001.00001.0001.0000
Hyperuricaemia1197131.092.114 (1.128 to 3.964)0.022.051 (1.063 to 3.856)0.03
Sensitive analysis
Total ‡
Normal SUA level5525170.311.0001.00001.0001.0000
Hyperuricaemia63591.424.658 (2.068 to 10.494)<0.0015.666 (2.383 to 13.473)<0.001
Total §
Normal SUA level7699370.481.0001.00001.0001.0000
Hyperuricaemia1191131.092.285 (1.211 to 4.312)0.012.183 (1.132 to 4.212)0.02
  • *Model 1: adjusted for age, smoking, alcohol use, diuretics use, statins use, hypertension, diabetes, MI, TIA/stroke and dyslipidaemia, heart failure and gout.

  • †Model 2: adjusted for model 1 and sex.

  • ‡Model 3: adjusted for model 2 and further excluded subjects with hypertension.

  • §Model 4: adjusted for model 2 and further excluded subjects with MI or heart failure.

  • AF,  atrial fibrillation; MI,  myocardial infarction; SUA, serum uric acid; TIA,  transient ischaemic attack.